IL2 and neoplasm: Comparing methods of delivery in a mouse neuroblastoma model, intratumoral hu14.18-IL-2 antitumor effect is driven by NK cells and T cells and increases tumor infiltrating T and NK activation, resulting in better inhibition of tumor growth and survival compared to intravenous immunocytokine [137].